1. Contractors
  2. Oxos Medical Inc

Oxos Medical Inc

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Oxos Medical has 1 federal contract of $100,000 or more active since October 2023, with $9.57M obligated, from 1 agency. 1 is still running.

Contracts
1 since FY2024$9,574,161 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
Office of Assistant Secretary for Preparedness and Response$9.57M on 1 contract
UEI
D3KFHYMV6B17Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Develop and Validate the Oxos X3, a Portable X-Ray System Designed to Transform Trauma Response by Bringing Hospital-Grade Imaging Directly to the Point of Need. This Effort Will Eliminate Critical…Office of Assistant Secretary for Preparedness and Response · 75A50126C00011$9,574,161Oct 4, 2028in 22 monthsGA

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Office of Assistant Secretary for Preparedness and Response1 contract$9,574,161

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract$9,574,161

Where the work is

Place of workAmount
Georgia1 contract$9,574,161

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like Oxos Medical's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy